InvestorsHub Logo
Followers 43
Posts 2346
Boards Moderated 0
Alias Born 12/17/2001

Re: EM post# 6176

Tuesday, 12/26/2017 6:52:21 PM

Tuesday, December 26, 2017 6:52:21 PM

Post# of 8449
I think KTOV advantage might be that KIT-302 is a combination of 2 prescription drugs and not OTC (like Horizon's drug).

But I still think the market will be more challenging, due to higher public awareness of price gauging by drug companies.
Still, they don't need much for success.....(I got a small position, but might increase it, based on future development).